|1.||Walsh, Thomas J: 17 articles (12/2015 - 01/2002)|
|2.||Roilides, Emmanuel: 9 articles (12/2015 - 07/2007)|
|3.||Lewis, Russell E: 8 articles (09/2015 - 05/2008)|
|4.||Kontoyiannis, Dimitrios P: 8 articles (08/2014 - 12/2003)|
|5.||Glöckner, A: 6 articles (08/2015 - 05/2010)|
|6.||Kauffman, Carol A: 5 articles (10/2015 - 04/2004)|
|7.||Drew, Richard H: 5 articles (08/2011 - 05/2006)|
|8.||Petraitis, Vidmantas: 4 articles (12/2015 - 01/2002)|
|9.||Katragkou, Aspasia: 4 articles (12/2015 - 06/2011)|
|10.||Viscoli, Claudio: 4 articles (12/2013 - 01/2010)|
03/01/2007 - "Overall, the three echinocandins are relatively safe and effective agents for the treatment of Candida infections."
12/01/2009 - "The three echinocandins were similarly effective in the treatment of experimental disseminated infections with C. "
12/01/2008 - "The echinocandins are a new class of antifungal agent that has shown promising results in the treatment of numerous invasive fungal infections. "
11/01/2006 - "The echinocandins are a new class of antifungal that have shown promising results in treating a variety of fungal infections. "
07/15/2006 - "Echinocandins are a new class of drugs that have shown promising results in treating a variety of fungal infections. "
10/01/2007 - "The echinocandins have potent fungicidal activity against most Candida species, but there are few data comparing the safety and efficacy of echinocandins in the treatment of invasive candidiasis. "
07/01/2014 - "Echinocandins are employed as the first-line treatment for invasive candidiasis until the fungal species is determined and confirmed by clinical diagnosis. "
01/01/2014 - "Echinocandins are indicated as first-line treatment for invasive candidiasis in moderate to severe illness. "
08/01/2008 - "The echinocandins as a class offer an advance in the treatment of invasive candidiasis, an additional option for prophylaxis and an attractive choice for the study of combination antifungal therapy. "
12/01/2015 - "The current standard of treatment of invasive candidiasis with echinocandins requires once-daily therapy. "
01/01/2015 - "However, studies demonstrating the clinical effectiveness of echinocandins in comparison with antifungals currently recommended for first-line treatment of invasive aspergillosis are still lacking. "
10/01/2006 - "By contrast, the demonstrated efficacy of the echinocandins for the treatment of invasive aspergillosis has been based on historically controlled salvage treatment trials in patients failing or intolerant of other therapies. "
07/01/2007 - "Combination therapy with echinocandins plus other licensed antifungal therapy shows promise in treating invasive aspergillosis. "
12/01/2011 - "Current role of echinocandins in the management of invasive aspergillosis."
01/01/2009 - "Echinocandins represent a safe and well tolerated option for the therapy of invasive aspergillosis in patients who are unable to tolerate other agents or have refractory disease. "
|4.||Critical Illness (Critically Ill)
04/01/2012 - "Echinocandins are the first line treatment for IC in critically ill patients with mild or severe illness. "
12/01/2015 - "To conclude, adminstration of echinocandins in this observed study population is safe, even in severely critically ill patients if application rules of these agents are followed. "
12/01/2015 - "Therefore, treatment guidelines recommend echinocandins as first-line antifungals in critically ill patients to improve patient outcomes. "
03/01/2015 - "Echinocandins have become the agents of choice for early and specific antifungal treatment in critically ill patients. "
02/01/2014 - "Echinocandins have become the agents of choice for early and specific antifungal treatment in critically ill patients. "
11/01/2015 - "Echinocandins have in vitro activity against most Candida spp. and are the first-line agents in the treatment of candidemia. "
10/01/2015 - "The antifungal drugs used to treat candidemia are mainly the echinocandins, however some isolates may be resistant to these drugs. "
09/01/2015 - "The diminished macrophage inflammatory response to isolates that caused persistent candidemia and differential immunopharmacologic activity of echinocandins among FKS mutants suggest that certain strains of C. "
10/01/2014 - "The use of echinocandins as primary therapy for candidemia appears to be associated with better outcomes."
09/15/2014 - "Echinocandins are recommended for Candia glabrata candidemia. "
|1.||Amphotericin B (Amphotericin)
|4.||Transplantation (Transplant Recipients)
|5.||Hematopoietic Stem Cell Transplantation